176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.97%
Revenue growth under 50% of INTC's 12.13%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
4.02%
Gross profit growth at 50-75% of INTC's 6.47%. Martin Whitman would question if cost structure or brand is lagging.
9.76%
EBIT growth above 1.5x INTC's 3.36%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
9.76%
Operating income growth above 1.5x INTC's 3.36%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
4.97%
Positive net income growth while INTC is negative. John Neff might see a big relative performance advantage.
5.26%
EPS growth above 1.5x INTC's 1.75%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
1.75%
Diluted EPS growth of 1.75% while INTC is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
1.63%
Slight or no buybacks while INTC is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
2.89%
Slight or no buyback while INTC is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-107.79%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-148.16%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
352.22%
10Y revenue/share CAGR above 1.5x INTC's 137.19%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
53.06%
5Y revenue/share CAGR similar to INTC's 54.30%. Walter Schloss might see both companies benefiting from the same mid-term trends.
13.23%
3Y revenue/share CAGR under 50% of INTC's 40.97%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-134.04%
Negative 10Y OCF/share CAGR while INTC stands at 318.89%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-105.37%
Negative 5Y OCF/share CAGR while INTC is at 105.58%. Joel Greenblatt would question the firm’s operational model or cost structure.
-101.68%
Negative 3Y OCF/share CAGR while INTC stands at 92.31%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
404.31%
Net income/share CAGR at 50-75% of INTC's 703.20%. Martin Whitman might question if the firm’s product or cost base lags behind.
90.46%
5Y net income/share CAGR at 50-75% of INTC's 150.04%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-0.72%
Negative 3Y CAGR while INTC is 132.44%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
1080.32%
10Y equity/share CAGR above 1.5x INTC's 58.11%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
107.36%
5Y equity/share CAGR above 1.5x INTC's 47.97%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
30.25%
3Y equity/share CAGR 1.25-1.5x INTC's 23.61%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
41.26%
AR growth well above INTC's 23.54%. Michael Burry fears inflated revenue or higher default risk in the near future.
17.38%
Inventory growth well above INTC's 9.10%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.05%
Asset growth above 1.5x INTC's 3.74%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.61%
Positive BV/share change while INTC is negative. John Neff sees a clear edge over a competitor losing equity.
-1.44%
We’re deleveraging while INTC stands at 1.04%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
0.86%
R&D dropping or stable vs. INTC's 14.66%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.05%
SG&A growth well above INTC's 4.11%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.